Segui La Zampa su Facebook (clicca qui), Instagram (clicca qui) e X (clicca qui) - Non perderti le migliori notizie e storie, ...
Corvus Pharmaceuticals is being revisited after a 25% stock decline since my last article on this clinical-stage name late in 2024. The company continues to advance its primary drug candidate against ...
SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Corvus Pharmaceuticals Inc. (CRVS) on Tuesday reported a loss of $10.2 million in its third quarter. The South San Francisco, ...
This media is in the public domain (free of copyright restrictions). You can copy, modify, and distribute this work without contacting the Smithsonian. For more information, visit the Smithsonian's ...
L3 Harrisʼ Corvus EW system integrated onto a Rheinmetall 4×4 vehicle at DSEI 2025. (Janes/Tom Barton) L3 Harris integrated its Corvus electronic warfare (EW) system on a Rheinmetall patrol vehicle ...
SOUTH SAN FRANCISCO, Calif., Oct. 02, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, announced today that David Moore, Executive Vice ...
Corvus Robotics’ innovative storage tracking system uses fully autonomous drones to take warehouse inventory control to new heights. The Corvus One Autonomous Inventory Management System provides ...
Corvus' lead asset soquelitinib shows promise in both oncology and autoimmune - Phase 3 PTCL data and AD trial updates are key upcoming catalysts. The company faces high risk due to limited cash, ...
SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Corvus Pharmaceuticals Inc. (CRVS) on Thursday reported net income of $15 million in its first quarter. On a per-share basis, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback